IGFBP6 and nasopharyngeal carcinoma: They suggested that more aggressive treatment, such as radiotherapy or targeted chemotherapy, may be advised in NPC patients negative for IGFBP6, who are more likely to experience distant metastasis (Chen et al., 2016).